Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles
Apo C-III modulates VLDL
Apo C-III in apo B particles is atherogenic
Relationship between apo C-III in apo B containing lipoproteins and atherogenicity
PROCAM Study MI-Incidence according to LDL-cholesterol and triglycerides
PROCAM Study CHD risk according to LDL-C and TG increased TG confers raised CHD risk at all levels of LDL-C
HDL: an anti-atherogenic lipoprotein
HDL metabolism: 5 key genes
HDL: apo AI-rich particles
Apo A-I protects against atherosclerosis
Apo A-II protects against atherosclerosis The human apo A-II transgenic mouse model